Acorda Therapeutics, Inc. - Common Stock (NQ:ACOR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 11, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Acorda Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

92 Biggest Movers From Friday ↗

May 09, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...

Via Benzinga

Acorda First Quarter 2022 Update: Webcast/Conference Call Scheduled for May 11, 2022

May 04, 2022

From Acorda Therapeutics, Inc.

Via Business Wire

78 Biggest Movers From Yesterday ↗

March 11, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 01, 2022

On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 10, 2022

Gainers Salarius Pharmaceuticals (NASDAQ:SLRX) stock moved upwards by 31.4% to $0.49 during Thursday's regular session. The current volume of 2.4 million shares is 738...

Via Benzinga

45 Stocks Moving In Thursday's Mid-Day Session ↗

March 10, 2022

Gainers CEA Industries Inc. (NASDAQ: CEAD) shares surged 33.4% to $2.7350 after the company reported it signed a $2.1 million contract. Yield10 Bioscience, Inc. (NASDAQ: YTEN)...

Via Benzinga

The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute ↗

March 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus AbbVie Settles With Alvotech On Humira Biosimilar Patent Dispute AbbVie, Inc...

Via Benzinga

Earnings Scheduled For March 9, 2022 ↗

March 09, 2022

Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

Acorda Fourth Quarter/Year End 2021 Update: Webcast/Conference Call Scheduled for March 9, 2022

February 24, 2022

From Acorda Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 20, 2022

Gainers TCR2 Therapeutics (NASDAQ:TCRR) s...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 19, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR)...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 14, 2022

Gainers Avinger (NASDAQ:AVGR) stock moved...

Via Benzinga

Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

January 04, 2022

From Acorda Therapeutics, Inc.

Via Business Wire

John Varian Joins Acorda Therapeutics Board of Directors

January 03, 2022

From Acorda Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 17, 2021

Gainers Rani Therapeutics Hldgs (NASDAQ:RA...

Via Benzinga

Acorda Inks Distribution Pact In Germany For Inhaled Levodopa Powder; Q3 Earnings Beat Expectations ↗

November 10, 2021

Acorda Therapeutics Inc (NASDAQ: ACOR) entered into distribution and supply agreements with Esteve Pharmaceuticals GmbH to commercialize Inbrija 33 mg (...

Via Benzinga

Topics Earnings

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany

November 09, 2021

From Acorda Therapeutics, Inc.

Via Business Wire

Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team

November 09, 2021

From Acorda Therapeutics, Inc.

Via Business Wire

Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021

November 02, 2021

From Acorda Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 22, 2021

Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. T2...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 24, 2021

Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume for Molecular Templates's stock is 937.9K as...

Via Benzinga

Acorda Therapeutics Announces Corporate Restructuring, Management Changes

September 09, 2021

From Acorda Therapeutics, Inc.

Via Business Wire

Return on Capital Employed Insights for Acorda Therapeutics ↗

August 26, 2021

After pulling data from Benzinga Pro it seems like during Q2, Acorda Therapeutics (NASDAQ:ACOR) posted sales of $31.79 million. Earnings were up 42.24%, but Acorda Therapeutics...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 26, 2021

Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The company's market cap stands at $8.1 billion....

Via Benzinga

Acorda Therapeutics Reports Second Quarter 2021 Financial Results

August 05, 2021

From Acorda Therapeutics, Inc.

Via Business Wire

Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021

July 30, 2021

From Acorda Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 26, 2021

Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million....

Via Benzinga

84 Biggest Movers From Friday ↗

August 09, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...

Via Benzinga

40 Stocks Moving in Monday's Pre-Market Session ↗

July 26, 2021

Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.